Search tips
Search criteria 


Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Circ Cardiovasc Imaging. Author manuscript; available in PMC 2010 November 1.
Published in final edited form as:
PMCID: PMC2782553

Influence of Myocardial Fibrosis on Left Ventricular Diastolic Function: Non-Invasive Assessment by CMR and ECHO

Antonella Moreo, MD,1,2 Giuseppe Ambrosio, MD, PhD, FAHA,3 Benedetta De Chiara, MD,2 Min Pu, MD,1 Tam Tran, BS,1 Francesco Mauri, MD,2 and Subha V. Raman, MD, MSEE1



Fibrosis is a common endpoint of many pathologic processes affecting the myocardium, and may alter myocardial relaxation properties. By measuring myocardial fibrosis with CMR and diastolic function with Doppler echocardiography, we sought to define the influence of fibrosis on left ventricular (LV) diastolic function.

Methods and Results

204 eligible subjects from 252 consecutive undergoing late post-gadolinium myocardial enhancement cardiac magnetic resonance (LGE-CMR) and Doppler echocardiography were investigated. Subjects with normal diastolic function exhibited no or minimal fibrosis (median LGE score 0, IQR 0 – 0). In contrast, the majority of patients with cardiomyopathy (regardless of etiology) had abnormal diastolic function indices and substantial fibrosis (median LGE score 3, IQR 0 – 6.25). Prevalence of LGE-positivity by diastolic filling pattern was 13% in normal, 48% in impaired relaxation, 78% in pseudo-normal and 87% in restrictive filling (p<0.0001). Similarly, LGE score was significantly higher in patients with deceleration time <150ms (p<0.012), and it also progressively increased with increasing LV filling pressure estimated by TDI-derived E/E’ (p<0.0001). After multivariate analysis, LGE remained significantly correlated with degree of diastolic dysfunction (p=0.0001).


Severity of myocardial fibrosis by LGE significantly correlates with the degree of diastolic dysfunction in a broad range of cardiac conditions. Non-invasive assessment of myocardial fibrosis may provide valuable insights into the pathophysiology of LV diastolic function and therapeutic response.

Keywords: diastole, myocardium, collagen, magnetic resonance imaging, echocardiography

Diastolic dysfunction significantly influences prognosis in chronic heart disease across multiple etiologies; it is present in virtually all patients with heart failure14 as well as less severe conditions57. From a mechanistic point of view, it can be traced to abnormalities of left ventricular (LV) distensibility, filling or relaxation8. These alterations may coexist and act in synergy to influence LV diastolic function8.

Accumulating evidence indicates that myocardial fibrosis contributes to the pathogenesis of diastolic dysfunction9,10. This is quite conceivable, as the structural properties of the heart are determined not only by myocyte network but also by interstitial connective tissue. Thus, changes in the amount and composition of extracellular matrix should affect the diastolic properties of LV11. However, our ability to investigate this issue in patients has long been hampered by lack of suitable methodology, since investigations thus far have been restricted to evaluating cardiac fibrosis in tissue biopsies or at autopsy1214.

Late post-gadolinium myocardial enhancement (LGE) by cardiac magnetic resonance (CMR) has long been used to detect presence of scar after myocardial infarction15. More recently, LGE-CMR has been shown to provide an accurate, non-invasive means of detecting myocardial fibrosis due to various forms of nonischemic cardiomyopathy, and has been validated against histopathological examination16,17. Distinct hyperenhancement patterns occur in different myocardial disorders that all share tissue disarray, fibrosis, and inflammation1822. Regardless of initial etiology, myocyte injury ultimately leads to increased myocardial collagen content and expanded interstitial space23. Extracellular contrast agents such as gadolinium-chelates accumulate in such regions, leading to hyperenhancement on imaging that takes advantage of gadolinium’s T1-shortening effects.

In the present study, we used LGE-CMR combined with established Doppler flow and tissue velocity measurement techniques24 to investigate non-invasively whether myocardial fibrosis influences diastolic function.


The study population comprised patients referred for CMR with LGE and in whom echocardiography with Doppler assessment of transmitral flow and tissue Doppler imaging was performed within 30 days of CMR. All patients were in stable sinus rhythm. Out of 252 patients screened, 22 were excluded due to complex congenital heart disease, 12 had mitral stenosis or valve prosthesis, 12 had constrictive pericarditis or significant pericardial effusion and 2 had prior surgical ventricular restoration. CMR and echo studies were independently analyzed by expert investigators unaware of imaging and clinical data. This study was performed with Institutional Review Board approval.

CMR acquisition and analysis

All scans were acquired with a 1.5 Tesla magnetic resonance scanner (MAGNETOM Avanto, Siemens Medical Solutions, Inc., Erlangen, Germany). Multislice short axis cine imaging used ECG-triggered, steady-state free-precession (slice thickness 8 mm, interslice gap 2 mm) acquired from the atrioventricular ring to the apex25. Late gadolinium imaging was performed 5–10 minutes after intravenous gadolinium-DTPA contrast administration (0.2 mmol/kg) using a T1-weighted inversion-recovery gradient echo sequence26, optimizing the inversion time for adequate myocardial suppression and scar visualization.

Magnetic resonance examinations were analyzed by an experienced CMR physician blinded to patient history and echocardiographic data. LV volumes, mass, and ejection fraction (EF) were measured from contiguous short-axis cine images using endocardial and epicardial contours and end-systole and end-diastole and Simpson’s rule, where the volumes from each short-axis slice were summed to obtain global measures. Wall motion score index (WMSI) was calculated using a standard 17-segment model27 and 4-point scoring system (0=normal/hyperkinetic, 1=hypokinetic, 2=akinetic, 3=paradoxical/dyskinetic). Regional wall motion score indices were obtained by summing the basal, mid and apical segment scores in each region, as follows: anterior (anterior and antero-lateral), septal (anteroseptum and inferoseptum), and inferior (inferior and inferolateral).

Similarly, LGE was rated by visual assessment blinded to echo and clinical data as 0=none, 1=non-transmural, or 2=transmural in each of the 17 myocardial segments. The LGE score was computed for each patient as the 17-segment sum of these ratings. Regional LGE scores (anterior, septal and inferior) were calculated similarly to the above described regional WMSI scores.

Echocardiography acquisition and analysis

Standard echocardiographic and Doppler recordings were performed by experienced sonographers. Echo images were stored in digital format for subsequent off-line analysis by experienced investigators unaware of CMR results. Vivid-7 System (Vingmed-General Electric, Milwaukee, WI), Sonos 5500 (Philips Medical Systems, Andover, MA), and ie33 (Philips Medical Systems) with a 3.5 MHz probe were used for echocardiography. Mitral diastolic inflow was interrogated using pulsed-wave Doppler from the apical 4-chamber view with the sample volume placed at the level of the mitral leaflet tips. Mitral early diastolic peak (E wave), late peak (A wave) velocities, E/A ratio, and deceleration time (DT) of mitral early velocity were measured5,28,29. Tissue Doppler was obtained at the apical four-chamber view with the sample volume placed at the lateral mitral annulus. Early diastolic mitral annulus peak velocity was measured, and ratio of transmitral diastolic peak velocity to the mitral annular diastolic peak velocity (E/E’) was calculated24,30. Data were averaged over 3 cardiac cycles. Classification of diastolic function as normal, mild dysfunction (impaired relaxation), moderate dysfunction (pseudonormal), and severe dysfunction (restrictive filling pattern) was performed according to standard criteria5,28,29. The E/E’ ratio was used to estimate LV filling pressures. Based on E/E' cut-off value of 10, patients were categorized as having normal or elevated filling pressure30.

Statistical analysis

Continuous variables are expressed as median and interquartile ranges (IQR) or mean±95% confidence intervals (95% IC). Differences between groups were compared using Student’s t-test and Mann–Whitney’s U-test when the distribution of the variable was asymmetrical; Fisher’s exact test was used for categorical variables. Spearman’s correlation was used to test the correlation between continuous variables; differences between groups were tested by ANOVA with Bonferroni post-hoc test. Association between E/E’or E’ and LGE was first evaluated by quadratic model (LGE= − β0+ β1E/E’ − β2E/E’ 2; LGE= β0− β1E’ + β2E’ 2 ). Then, association between E/E’ and age, echocardiographic and CMR data was evaluated by linear regression analysis. Only variables significant at univariate analysis were entered into a multiple linear regression analysis. Statistical significance was set at a p value <0.05. Statistical analyses were carried out with the Statistical Package for the Social Sciences (SPSS Inc., Chicago, IL, USA) release 13.0 for Windows.


Patient characteristics

From January to August 2007, 204 suitable subjects were identified. Of them, 42 (20%) had no evidence of structural heart disease; these patients were typically referred for CMR because of a questionable abnormality seen on echocardiography, or to ‘rule out’ arrhythmogenic right ventricular cardiomyopathy in the setting of isolated ventricular premature beats. The remaining patients had various cardiac diagnoses; their clinical and demographic characteristics are summarized in Table I.

Table 1
Baseline Demographic, Clinical and Imaging Characteristics (N = 204 patients)

CMR findings

In the overall population, CMR-derived median LV EF was 50% (IQR 27 – 58%), end-diastolic and end-systolic volumes indexed to body surface area were 72 (59 – 97) ml/m2, and 36 (26 – 63) ml/m2, respectively, and LV mass index was 65 (50 – 89) g/m2.

All cardiac segments were adequately visualized by CMR in every patient. 104 (51%) patients demonstrated LGE positivity in one or more segments; of the 515 LGE-positive segments, distribution pattern of LGE was transmural in 216 segments (42%), and non-transmural in 299 (58%). Importantly, no LGE-positive segments were detected in subjects without structural heart disease. In contrast, LGE positivity was quite common in patients with cardiomyopathy, being present in 89% of patients with ischemic cardiomyopathy, in 59% of those with dilated cardiomyopathy, and in 67% of those with hypertrophic cardiomyopathy. The median LGE score was 0 (IQR 0.00 – 0.00) in subjects without structural heart disease compared to 3 (IQR 0 – 6.25) in patients with cardiomyopathy (p<0.0001). Severity of LGE score showed a significant inverse correlation with LV EF (r=−0.51; p<0.0001).

Echo findings

A pattern of abnormal diastolic filling based on mitral inflow velocities was seen in 113 patients (51%); furthermore, 26 (16%) had severely impaired diastolic filling, as indicated by a deceleration time (DT) <150msec 5,28,29.

Assessment of left ventricular diastolic function was completed by measuring E/E’ by tissue Doppler, as this parameter provides an accurate, relatively load-independent estimate of LV filling pressure31,32; diastolic impairment with increased LV filling pressure (E/E’ >10) 30 was present in 80 patients (39%).

Diastolic function and LGE

Overall, 63 (31%) subjects had normal diastolic function by concomitant presence of all three criteria i.e., normal mitral inflow pattern, DT ≥150 ms, and E/E’ ≤10. Importantly, no LGE was detected in the vast majority (87%) of these subjects with entirely normal diastolic function; overall, median LGE score in these patients was 0 (IQR 0.00 – 0.01). Across the entire study population, LGE positivity was significantly associated with all parameters of diastolic dysfunction. Median LGE score in subjects who showed normal filling was 0 (IQR 0.00 – 0.01), but it significantly and progressively increased with increasing severity of filling impairment, reaching 4 (IQR 2 – 10) in patients with restrictive filling pattern (Fig.1; p<0.0001). Similarly, LGE was significantly higher in patients in whom deceleration time was <150 ms, compared with patients with normal deceleration time (Fig. 2; p=0.012). Finally, degree of fibrosis as assessed by LGE score also significantly increased with increasing severity of LV filling pressure estimated by E/E’ (≤10 vs >10) (Fig. 3; p<0.0001). Conversely, of the 100 LGE-negative patients, 86 had normal diastolic function by E/E’ ≤10.

Figure 1
LGE score as a function of left ventricular diastolic function indicated progressive, significant increase in fibrosis with each successive grade of diastolic dysfunction. Box-and-whisker plot indicates median and interquartile ranges along with outliers ...
Figure 2
LGE score was significantly higher indicating greater fibrosis in patients with short deceleration times (DT <150 ms). Box-and-whisker plot indicates median and interquartile ranges along with outliers that fall above the confidence interval.
Figure 3
LGE score as a function of estimated left ventricular end-diastolic pressure showed significant differences between patients with E/E’ ≤10 vs. E/E’>10. Box-and-whisker plot indicates median and interquartile ranges along ...

At the individual level, fibrosis by LGE was directly and significantly correlated with E/E’ (LGE= −1.477 + 0.538 E/E’ − 0.003 E/E’ 2; S.E. of β0=1.325, β1=0.203, β2= 0.006; r = 0.444; P<0.001); similarly, LGE was also significantly related to the E’ component (LGE= 11.006 − 102.935 E’+ 257.109 E’2; S.E. of β0=1.989, β1=35.625, β2= 143,547; r = 0.356; P<0.001). Analysis of patients divided into those with EF ≥50% and those with EF <50% showed that the relationship between LGE and diastolic function remained statistically significant in both groups (p<0.001; r=0.28 and 0.44, respectively). Additional plots of the individual LGE scores and diastolic function parameters are shown in Figure 4.

Figure 4
Individual values for deceleration time (DT) vs. LGE score (left) and E/E’ vs. LGE score (right) are shown.

Chi-square analysis showed a significant association between LGE positivity and presence/absence of any diastolic dysfunction (χ2 = 53, p<0.0001). Univariate analysis showed significant correlations between diastolic dysfunction assessed by E/E’ and age, diabetes, hypertension, type of heart disease, EF, WMSI, and LGE score (p<0.05, for all). After multivariate analysis, only age, diabetes and LGE score remained significantly and independent correlated with the degree of diastolic dysfunction (Table II). We checked collinearity for variables, and the tolerance was near 0.9 for all variables

Table 2
Multivariate Analysis of Variables Associated with Increased Left Ventricular Filling Pressure


In a large cross-sectional study that included a broad range of cardiac conditions as well as patients without structural heart disease, we found that presence and severity of left ventricular diastolic dysfunction was consistently associated with myocardial enhancement on LGE-CMR. Intact cardiomycytes do not show LGE-positivity, underscoring the ability of LGE to demonstrate altered myocardial composition that contributes to impaired diastolic function. Previous reports had shown a relationship between degree of cardiac fibrosis and diastolic dysfunction1013,33; however, those studies relied on evaluation of collagen deposition as assessed by histological examination of tissue specimens. While accurate, those investigations were obviously limited with respect to number of patients studied and because of relative exclusion of subjects with no structural heart disease. To our knowledge, ours is the first study to investigate the relationship between LV diastolic dysfunction and severity and location of myocardial fibrosis in a large cohort of patients with various extent of cardiac impairment.

LV filling and myocyte relaxation show a complex interplay during diastole, which is influenced by many factors including loading conditions, systolic emptying, myocardial ischemia, heart rate, and intracellular calcium cycling34. Physical properties of the myocardium also play a very relevant role in dictating LV behavior during diastole9. In this respect, collagen is an important constituent of the myocardial extracellular matrix, and changes in its structure can affect diastolic function. Increased tissue collagen deposition alters the viscoelasticity of the myocardium impairing relaxation, diastolic recoil (i.e., “suction”) and passive stiffness. The heart’s collagen network consists of epimysial, perimysial, and endomysial components, around which muscle fibers are oriented9. The LV develops a negative diastolic pressure (suction) when coiled perimysial fibers release the energy stored during systolic compression; this contributes to diastolic filling that, hence, is not entirely passive. Micro- and macro-disarray of these components, especially of perimysial fibers, have been implicated in the pathogenesis of diastolic dysfunction33. Yet, while undoubtedly relevant to understanding the pathophysiology of diastole, systematic investigation of cardiac fibrosis and of its relationship with diastolic function has long been hampered by lack of suitable methodology.

LGE-CMR is a well-established technique to non-invasively detect foci of collagen deposition in vivo. Importantly, it has been documented that LGE results show a good correlation with direct histological findings35,36. While originally associated with infarct scar visualization in ischemic heart disease, distinct patterns of hyperenhancement have subsequently been described in dilated cardiomyopathy, hypertrophic cardiomyopathy, and other myocardial diseases1820,22,37,38. Our population included subjects without structural heart disease as well as patients with a wide spectrum of heart diseases of different etiology; the percentages of LGE positivity that we found in those various conditions compares well with what has been previously reported21,22.

By using a non-invasive approach, we were able to explore subjects spanning across a wide range of cardiac fibrosis and, at the same time, a wide range of degrees of diastolic function. This is important, since impaired diastolic function can be found also in many subjects with no overt cardiac disease, or even as the initial cardiac manifestation of aging. We confirmed in our study the well-known correlation between aging and myocardial relaxation impairment, demonstrating that age was correlated with diastolic function in multivariate analysis.

Since the degree of diastolic impairment may vary with the severity of disease, it is crucial to be able to detect and differentiate severity of diastolic dysfunction. We investigated diastolic function by a multi-pronged approach based on well-established echocardiographic techniques. One is pulsed-wave Doppler evaluation of transmitral inflow velocities; by this approach, distinct filling patterns have been described representing various degrees of diastolic impairment, from normal LV filling to restrictive physiology5,8. The most benign alteration, termed impaired relaxation (grade I) and characterized by prolonged deceleration time of early diastolic filling and decreased E/A, is associated with delayed relaxation in the presence of normal LV filling pressures. At the other end of the spectrum, a restrictive filling pattern (grade III) is characterized by shortened deceleration time, increased E/A, and shortened relaxation time, and reflects high LV filling pressures. The pseudonormal filling pattern (grade II) is considered a condition of intermediate severity. Our data are consistent with this concept of a gradient of severity in diastolic dysfunction, paralleled by a relationship between degree of diastolic impairment and extent of myocardial fibrosis by LGE-CMR (Fig. 1). This finding was confirmed when impairment of diastolic filling dynamics was established with respect to deceleration time of early atrial empting. It is well established that DT <150 ms denotes a condition of severe impairment of diastolic empting, associated with increased atrial pressures and poor systolic function 5,28,29. Our data indicated that patients with DT <150 ms have significantly greater myocardial fibrosis (Fig. 2).

Doppler evaluation of LV filling may be influenced by both preload and afterload. To overcome this limitation, we simultaneously assessed diastolic function using mitral annular velocity by tissue Doppler imaging (TDI) – a sensitive, reliable, and relatively load-independent index of diastolic function24. Again, we demonstrated progressive increase in extent of fibrosis with progressive increase in LV filling pressure as estimated by TDI (Fig. 3). Indeed, there was a significant correlation between either E’ or E/E’ and the degree of LGE enhancement.

We did not find any significant correlation between E/E’ and etiology of heart disease; in addition to the severity of fibrosis, only its location in the septum was significantly and independently associated with E/E’, and this regardless of etiology. We have no immediate explanation for the observed correlation between E/E’ and septal fibrosis, although it may underscore the septum’s role in LV filling, either directly, or as a consequence of altered interventricular dependence, which in turn may affect diastolic function39.


In the present study, we did not attempt to dissect out the various components of diastole, as analysis of how fibrosis impacts precise mechanisms of diastolic function was beyond the scope of this study. Absence of invasive measurement of atrial and ventricular pressures is another limitation since LV diastolic filling is sensitive to loading conditions. However, among noninvasive surrogates, TDI-derived E’ and E/E’ have been shown to correlate well with direct pressure–volume measurements obtained through conductance catheter24. Furthermore, we examined subjects in stable hemodynamic and clinical conditions. This, along with the fact that the relationship between LGE and diastolic function was consistently reproduced when employing either LV filling patterns by pulsed-wave Doppler or TDI parameters, indicates that our findings were unlikely to be an effect of different loading conditions. Distinction among specific cardiac conditions was not done; rather, the goals of this work were to (1) consider diastolic function as a common endpoint in patients with a broad spectrum of disorders and those with normal cardiac structure, and (2) demonstrate altered myocardial tissue characterization as potential substrate for diastolic dysfunction. We did not employ techniques such as myocardial tagging to assess diastolic function by CMR 40; these could be used in future studies.

While we utilized a semiquantitative LGE score for practical implementation, direct signal intensity-based measurements would represent true quantification of LGE data. Age likely impacts fibrosis even in the absence of cardiac disease; however, our patients without cardiac disease were relatively young, precluding further analysis of this relationship. While accumulating histopathologic studies indicate that LGE likely represents fibrosis in patients with stable cardiac disease3638,41, accruing microscopy correlates may expand our understanding of the precise histopathologic signature responsible for LGE-positivity. Finally, the current resolution of CMR can detect only areas of fibrosis that are macroscopically visible; thus, collagen infiltration at the microscopic level goes undetected though it also likely contributes to diastolic dysfunction. Diffuse interstitial fibrosis, not readily appreciated by visual inspection of LGE images, may have been present in those patients deemed LGE-negative but found to have some degree of diastolic dysfunction. Future studies using CMR-based T1 mapping, a quantitative approach to measuring collagen volume fraction noninvasively, may overcome this limitation42.


There is increasing recognition of the importance in assessing diastolic function for both diagnosis and prognosis across a broad spectrum of cardiac conditions. Common to these conditions is reactive or replacement fibrosis that alters myocardial architecture and mechanical properties, and as indicated in our work produces measurable changes in diastolic function. Non-invasive evaluation of myocardial fibrosis allows analysis of a much large number of patients than is feasible with direct tissue examination. In addition, this approach lends itself well to serial measurements in investigating disease progression as well as treatment effects.

Another implication of our findings is the observation that etiology, in and of itself, seems to be less relevant than the presence and distribution of myocardial fibrosis in the pathophysiology of fibrosis-mediated diastolic impairment, since presence and severity of diastolic dysfunction were associated with presence and extent of fibrosis in various forms of underlying cardiac disease.


In patients with various degree of cardiac impairment, extent of cardiac fibrosis reliably predicts the degree of diastolic dysfunction. LGE-CMR provides a powerful means to non-invasively assess extent and location of myocardial fibrosis due to a variety of cardiac diseases. This, coupled with classification of diastolic function by echocardiography, provides insights into the mechanism of left ventricular diastolic dysfunction.

Myocardial fibrosis develops as a final common endpoint to in respond to a broad range of cardiac pathologies such as ischemia, inflammation, hypertension and valvular heart disease. Clinically, these conditions may produce signs and symptoms related to increased myocardial stiffness that may result from replacement or reactive fibrosis. This study used late gadolinium enhancement cardiac magnetic resonance imaging (LGE-CMR) to noninvasively quantify myocardial fibrosis and Doppler echocardiography to detect and classify severity of left ventricular diastolic dysfunction. Regardless of etiology, presence and severity of diastolic dysfunction increased with greater extent of myocardial fibrosis. This work suggests that LGE-CMR may be useful to identify the myocardial substrate for impaired relaxation, and provides a rationale for its use as an endpoint in developing novel therapeutics for diastolic dysfunction.


Funding Sources: NIH National Heart, Lung and Blood Institute R01 HL095563 (SVR)


Presented in part, at the 57th Annual Scientific Session of the American College of Cardiology, Chicago, IL, March 2008

Journal subject codes: [16] Myocardial cardiomyopathy disease, [30] CT and MRI, [31] Echocardiography, [110] Congestive

Conflict of Interest Disclosures: Dr. Raman receives research support from Siemens


1. Appleton CP, Hatle LK, Popp RL. Demonstration of restrictive ventricular physiology by Doppler echocardiography. J Am Coll Cardiol. 1988;11:757–768. [PubMed]
2. Lavine SJ, Arends D. Importance of the left ventricular filling pressure on diastolic filling in idiopathic dilated cardiomyopathy. Am J Cardiol. 1989;64:61–65. [PubMed]
3. Whalley GA, Doughty RN, Gamble GD, Wright SP, Walsh HJ, Muncaster SA, Sharpe N. Pseudonormal mitral filling pattern predicts hospital re-admission in patients with congestive heart failure. J Am Coll Cardiol. 2002;39:1787–1795. [PubMed]
4. Pinamonti B, Di Lenarda A, Sinagra G, Camerini F. Heart Muscle Disease Study Group. Restrictive left ventricular filling pattern in dilated cardiomyopathy assessed by Doppler echocardiography: clinical, echocardiographic and hemodynamic correlations and prognostic implications. J Am Coll Cardiol. 1993;22:808–815. [PubMed]
5. Nishimura RA, Tajik AJ. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone. J Am Coll Cardiol. 1997;30:8–18. [PubMed]
6. Muller-Brunotte R, Kahan T, Lopez B, Edner M, Gonzalez A, Diez J, Malmqvist K. Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) J Hypertens. 2007;25:1958–1966. [PubMed]
7. Galderisi M. Diastolic dysfunction and diabetic cardiomyopathy: evaluation by Doppler echocardiography. J Am Coll Cardiol. 2006;48:1548–1551. [PubMed]
8. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure:Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation. 2002;105:1387–1393. [PubMed]
9. Kass DA, Bronzwaer JG, Paulus WJ. What mechanisms underlie diastolic dysfunction in heart failure? Circ Res. 2004;94:1533–1542. [PubMed]
10. Burlew BS, Weber KT. Cardiac fibrosis as a cause of diastolic dysfunction. Herz. 2002;27:92–98. [PubMed]
11. Weber KT, Brilla CG, Janicki JS. Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc Res. 1993;27:341–348. [PubMed]
12. Querejeta R, Varo N, Lopez B, Larman M, Artinano E, Etayo JC, Martinez Ubago JL, Gutierrez-Stampa M, Emparanza JI, Gil MJ, Monreal I, Mindan JP, Diez J. Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease. Circulation. 2000;101:1729–1735. [PubMed]
13. Brilla CG, Funck RC, Rupp H. Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation. 2000;102:1388–1393. [PubMed]
14. Tanaka M, Fujiwara H, Onodera T, Wu DJ, Hamashima Y, Kawai C. Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy. Br Heart J. 1986;55:575–581. [PMC free article] [PubMed]
15. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445–1453. [PubMed]
16. Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H, Fritz P, Klingel K, Kandolf R, Sechtem U. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation. 2004;109:1250–1258. [PubMed]
17. Bocchi EA, Kalil R, Bacal F, de Lourdes Higuchi M, Meneghetti C, Magalhaes A, Belotti G, Ramires JA. Magnetic Resonance Imaging in Chronic Chagas' Disease: Correlation with Endomyocardial Biopsy Findings and Gallium-67 Cardiac Uptake. Echocardiography. 1998;15:279–288. [PubMed]
18. Debl K, Djavidani B, Buchner S, Lipke C, Nitz W, Feuerbach S, Riegger G, Luchner A. Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation of focal fibrosis. Heart. 2006;92:1447–1451. [PMC free article] [PubMed]
19. De Cobelli F, Pieroni M, Esposito A, Chimenti C, Belloni E, Mellone R, Canu T, Perseghin G, Gaudio C, Maseri A, Frustaci A, Del Maschio A. Delayed gadolinium-enhanced cardiac magnetic resonance in patients with chronic myocarditis presenting with heart failure or recurrent arrhythmias. J Am Coll Cardiol. 2006;47:1649–1654. [PubMed]
Choudhury L, Mahrholdt H, Wagner A, Choi KM, Elliott MD, Klocke FJ, Bonow RO, Judd RM, Kim RJ. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;40:2156–2164. [PubMed]
21. McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ, Pennell DJ. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 2003;108:54–59. [PubMed]
22. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J. 2005;26:1461–1474. [PubMed]
Rehwald WG, Fieno DS, Chen EL, Kim RJ, Judd RM. Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation. 2002;105:224–229. [PubMed]
24. Kasner M, Westermann D, Steendijk P, Gaub R, Wilkenshoff U, Weitmann K, Hoffmann W, Poller W, Schultheiss HP, Pauschinger M, Tschope C. Utility of Doppler echocardiography and tissue Doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction: a comparative Doppler-conductance catheterization study. Circulation. 2007;116:637–647. [PubMed]
25. Pennell DJ. Ventricular volume and mass by CMR. J Cardiovasc Magn Reson. 2002;4:507–513. [PubMed]
26. Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, Finn JP, Judd RM. An improved MR imaging technique for the visualization of myocardial infarction. Radiology. 2001;218:215–223. [PubMed]
27. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Int J Cardiovasc Imaging. 2002;18:539–542. [PubMed]
28. Rakowski H, Appleton C, Chan KL, Dumesnil JG, Honos G, Jue J, Koilpillai C, Lepage S, Martin RP, Mercier LA, O'Kelly B, Prieur T, Sanfilippo A, Sasson Z, Alvarez N, Pruitt R, Thompson C, Tomlinson C. Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: from the Investigators of Consensus on Diastolic Dysfunction by Echocardiography. J Am Soc Echocardiogr. 1996;9:736–760. [PubMed]
29. Garcia MJ, Thomas JD, Klein AL. New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol. 1998;32:865–875. [PubMed]
30. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol. 1997;30:1527–1533. [PubMed]
31. Thomas JD, Popovic ZB. Assessment of left ventricular function by cardiac ultrasound. J Am Coll Cardiol. 2006;48:2012–2025. [PubMed]
32. Van de Veire NR, De Sutter J, Bax JJ, Roelandt JR. Technological advances in tissue Doppler imaging echocardiography. Heart. 2008;94:1065–1074. [PubMed]
33. MacKenna DA, Omens JH, McCulloch AD, Covell JW. Contribution of collagen matrix to passive left ventricular mechanics in isolated rat hearts. Am J Physiol. 1994;266:H1007–H1018. [PubMed]
34. Lester SJ, Tajik AJ, Nishimura RA, Oh JK, Khandheria BK, Seward JB. Unlocking the mysteries of diastolic function: deciphering the Rosetta Stone 10 years later. J Am Coll Cardiol. 2008;51:679–689. [PubMed]
35. Papavassiliu T, Schnabel P, Schroder M, Borggrefe M. CMR scarring in a patient with hypertrophic cardiomyopathy correlates well with histological findings of fibrosis. Eur Heart J. 2005;26:2395. [PubMed]
36. Moon JC, Sheppard M, Reed E, Lee P, Elliott PM, Pennell DJ. The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease. J Cardiovasc Magn Reson. 2006;8:479–482. [PubMed]
37. Moon JC, Reed E, Sheppard MN, Elkington AG, Ho SY, Burke M, Petrou M, Pennell DJ. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2004;43:2260–2264. [PubMed]
38. Raman SV, Sparks EA, Baker PM, McCarthy B, Wooley CF. Mid-myocardial fibrosis by cardiac magnetic resonance in patients with lamin A/C cardiomyopathy: possible substrate for diastolic dysfunction. J Cardiovasc Magn Reson. 2007;9:907–913. [PubMed]
39. Baker AE, Dani R, Smith ER, Tyberg JV, Belenkie I. Quantitative assessment of independent contributions of pericardium and septum to direct ventricular interaction. Am J Physiol. 1998;275:H476–H483. [PubMed]
40. Reichek N. MRI myocardial tagging. J Magn Reson Imaging. 1999;10:609–616. [PubMed]
41. Sipola P, Peuhkurinen K, Lauerma K, Husso M, Jaaskelainen P, Laakso M, Aronen HJ, Risteli J, Kuusisto J. Myocardial late gadolinium enhancement is associated with raised serum amino-terminal propeptide of type III collagen concentrations in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha tropomyosin gene: magnetic resonance imaging study. Heart. 2006;92:1321–1322. [PMC free article] [PubMed]
42. Kehr E, Sono M, Chugh SS, Jerosch-Herold M. Gadolinium-enhanced magnetic resonance imaging for detection and quantification of fibrosis in human myocardium in vitro. Int J Cardiovasc Imaging. 2008;24:61–68. [PubMed]